Skip to content

News Hub

The latest breaking stories

Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.

NewsMatch Alert

Discover the most important & comprehensive stories delivered directly to you daily.

  • Medical Health Aged Care
  • 17/12/2024
  • 00:11
HistoSonics

HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

Feasibility Trial Evaluates Safety of Histotripsy to Destroy Pancreatic Tumors MINNEAPOLIS–BUSINESS WIRE– HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today…

  • Contains:
  • CharitiesAidWelfare
  • 17/12/2024
  • 00:01
The Salvation Army

“This will likely be the hardest Christmas in the Salvos’ 140-year history” – 6.3 million Aussies unable to afford housing, 1 in 4 concerned their kids will miss out on presents and a further 2.5 million concerned their kids will miss out on food this

17 December 2024 EMBARGOED AND NOT FOR RELEASE UNTIL 12.01AM, 17 DECEMBER 2024 “This will likely be the hardest Christmas in the Salvos’ 140-year history” 6.3 million Aussies unable to afford housing, 1 in 4 concerned their kids will miss out on presents and a further 2.5 million concerned their kids will miss out on food this Christmas, Salvation Army research finds The Salvation Army in Australia is gearing up for its biggest Christmas ever. New research shows 6.3 million Australians (29.9%) will struggle to pay their rent or mortgage this Christmas, and a shocking one in five (21%) being…

  • Contains:
  • Finance Investment
  • 16/12/2024
  • 23:55
Bitget Limited

Bitget Introduces LaunchX: A New Token Launch Platform Featuring Fuel Network as Its First Project

VICTORIA, Seychelles, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, announces the launch of LaunchX, a token launch platform that connects transformative blockchain projects with the global Web3 community, enabling effective early token distribution and adoption. The inaugural project to debut on LaunchX is Fuel Network (FUEL), an advanced blockchain solution that sets new standards for scalability, modularity, and efficiency in decentralized systems.LaunchX combines robust security with fair distribution practices, ensuring a user-centric environment for token launch and distribution. It supports blockchain projects by offering access to Bitget’s vast ecosystem of over 45 million…

  • Medical Health Aged Care
  • 16/12/2024
  • 23:11
Kinaxis Inc.

Biocodex Strengthens Supply Chain Resilience with Kinaxis

The human microbiota pioneer invests in an agile and transparent supply chain to better meet patient needs OTTAWA, Ontario–BUSINESS WIRE– Biocodex, a pioneer and…

  • Contains:
  • Medical Health Aged Care
  • 16/12/2024
  • 22:11
Brains Bioceutical Corp

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

VANCOUVER, British Columbia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (Brains Bio), a global leader in natural, GMP-compliant cannabinoid Active Pharmaceutical Ingredients (APIs), announces the expansion of its industry-leading offering. Cannabinol (CBN) is available as an EU-GMP certified API, D9-Tetrahydrocanabinol (THC) is in a solid crystalline form, undergoing enhanced stability optimization work and final validation work is being undertaken on Cannabigerol (CBG).These new additions complement Brains Bio's current portfolio, with the CBD API being used in over 30 clinical and pre-clinical studies, including a completed Phase III Refractory Epilepsy Study – submitted for Marketing Authorisation - and a…

  • Results Statistics
  • 16/12/2024
  • 21:42
The Lottery Corporation

Weekday Windfall Draw no. 4482 results for Monday, 16 December 2024

Weekday Windfall draw no. 4482 Draw Date: Monday, 16 December 2024 Drawn Numbers Winning Numbers 6 35 20 29 41 10 (drawn order) Supplementary Numbers 21 12 (drawn order) Dividends Dividend Total Winners Total Prizes Payable Division 1 $1,000,000.00 1 $1,000,000.00 Division 2 $4,781.00 12 $57,372.00 Division 3 $457.70 194 $88,793.80 Division 4 $28.35 8,914 $252,711.90 Division 5 $16.25 22,118 $359,417.50 Division 6 $11.85 51,361 $608,627.85 82,600 $2,366,923.05 Bloc Winners Summary VIC/TAS QLD NSW/ACT WA SA NT Division 1 0 0 1 0 0 0 Division 2 4 1 4 2 1 0 Division 3 51 30 63 32 17…

  • Contains:
  • Results Statistics
  • 16/12/2024
  • 21:17
The Lottery Corporation

Weekday Windfall Monday draw no. 4482, Lotto Strike draw no. 5560

Official Results Weekday Windfall Monday draw no. 4482 Draw Date: Monday, 16 December 2024 Drawn Numbers Winning Numbers (drawn order)[6] [35] [20] [29] [41] [10] Supplementary Numbers (drawn order)[21] [12] Division One Guaranteed Prize Offer (for up to 6 winners) $1,000,000.00 Total Prize Pool (Divisions 2 - 6) $1,366,002.56 Lotto Strike draw no. 5560 Drawn Numbers Winning Numbers (drawn order)[6] [35] [20] [29] Division One Prize Pool $423,096.45

  • Contains:
  • Science
  • 16/12/2024
  • 21:11
Biocytogen Pharmaceuticals

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need This…

  • Contains:
  • Medical Health Aged Care
  • 16/12/2024
  • 21:11
Sinovac Biotech Ltd.

SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)

The first phase III clinical trial on a multivalent HFMD vaccine in the world BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus 71 (EV71) and Coxsackievirus 16 (CA16). Notably, no multivalent vaccines against HFMD have yet been approved for marketing worldwide. The Phase III clinical trial is designed to be a multicenter, randomized, double-blind, controlled trial to evaluate the efficacy, safety and immunogenicity of this vaccine candidate…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.